These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1523 related items for PubMed ID: 8600797

  • 1. p53 expression is rare in cutaneous melanomas.
    Saenz-Santamaría MC, McNutt NS, Bogdany JK, Shea CR.
    Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions.
    Bergman R, Shemer A, Levy R, Friedman-Birnbaum R, Trau H, Lichtig C.
    Am J Dermatopathol; 1995 Dec; 17(6):547-50. PubMed ID: 8599466
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.
    Saenz-Santamaría MC, Reed JA, McNutt NS, Shea CR.
    J Cutan Pathol; 1994 Oct; 21(5):393-7. PubMed ID: 7868749
    [Abstract] [Full Text] [Related]

  • 4. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
    Reichrath J, Seyfried P, Braun R, Müller SM, Baum HP, Bahmer FA.
    Dermatology; 1997 Oct; 194(2):136-9. PubMed ID: 9094461
    [Abstract] [Full Text] [Related]

  • 5. p53 gene mutation and expression in naevi and melanomas.
    Sparrow LE, Soong R, Dawkins HJ, Iacopetta BJ, Heenan PJ.
    Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
    [Abstract] [Full Text] [Related]

  • 6. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
    Böni R, Doguoglu A, Burg G, Müller B, Dummer R.
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
    Essner R, Kuo CT, Wang H, Wen DR, Turner RR, Nguyen T, Hoon DS.
    Cancer; 1998 Jan 15; 82(2):309-16. PubMed ID: 9445187
    [Abstract] [Full Text] [Related]

  • 8. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T, Kitagawa M, Kasuga T.
    Virchows Arch A Pathol Anat Histopathol; 1993 Jan 15; 423(5):359-64. PubMed ID: 7906909
    [Abstract] [Full Text] [Related]

  • 9. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections.
    Skálová A, Michal M.
    Am J Dermatopathol; 1995 Aug 15; 17(4):332-4. PubMed ID: 8600794
    [Abstract] [Full Text] [Related]

  • 10. Mutation and expression of TP53 in malignant melanomas.
    Weiss J, Heine M, Arden KC, Körner B, Pilch H, Herbst RA, Jung EG.
    Recent Results Cancer Res; 1995 Aug 15; 139():137-54. PubMed ID: 7597286
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval.
    Piffkó J, Bánkfalvi A, Ofner D, Berens A, Tkotz T, Joos U, Böcker W, Schmid KW.
    J Oral Pathol Med; 1995 Sep 15; 24(8):337-42. PubMed ID: 7500288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF, Kamarashev J, Geertsen R, Böni R, Dummer R.
    Melanoma Res; 1998 Aug 15; 8(4):337-43. PubMed ID: 9764809
    [Abstract] [Full Text] [Related]

  • 17. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
    Itakura E, Huang RR, Wen DR, Paul E, Wünsch PH, Cochran AJ.
    Mod Pathol; 2008 Mar 15; 21(3):326-33. PubMed ID: 18204435
    [Abstract] [Full Text] [Related]

  • 18. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines.
    Rass K, Gutwein P, Welter C, Meineke V, Tilgen W, Reichrath J.
    Histochem J; 2001 Aug 15; 33(8):459-67. PubMed ID: 11931386
    [Abstract] [Full Text] [Related]

  • 19. Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
    Sharma BK, Smith CC, Laing JM, Rucker DA, Burnett JW, Aurelian L.
    Dermatology; 2006 Aug 15; 213(3):192-9. PubMed ID: 17033167
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.